Technical Analysis for IOBT - IO Biotech, Inc.

Grade Last Price % Change Price Change
B 10.13 -0.20% -0.02
IOBT closed down 0.2 percent on Tuesday, December 7, 2021, on 46 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical IOBT trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
NR7 Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
20 DMA Support Bullish -0.20%
Calm After Storm Range Contraction -0.20%
Multiple of Ten Bullish Other -0.20%
Wide Bands Range Expansion -0.20%
Older End-of-Day Signals for IOBT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 12 hours ago
Fell Below Previous Day's Low about 14 hours ago
Down 10% about 14 hours ago
60 Minute Opening Range Breakdown about 15 hours ago
20 DMA Support about 16 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops disruptive immune modulating anti-cancer therapies in Denmark. The company's lead product candidate, IO102-IO103, is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death ligand (PD-L1). It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. IO Biotech, Inc. was incorporated in 2021 and is based in Copenhagen, Denmark.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Immune System Cancers Cancer Therapies Treatment Of Cancers Urea Cycle Anti Cancer Therapies

Is IOBT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.88
52 Week Low 6.75
Average Volume 263,748
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 9.75
10-Day Moving Average 8.73
Average True Range 1.77
ADX 0.0
+DI 21.54
-DI 26.91
Chandelier Exit (Long, 3 ATRs) 12.58
Chandelier Exit (Short, 3 ATRs) 12.05
Upper Bollinger Bands 13.31
Lower Bollinger Band 6.20
Percent B (%b) 0.55
BandWidth 72.90
MACD Line -0.61
MACD Signal Line -0.74
MACD Histogram 0.129
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.81
Resistance 3 (R3) 11.63 10.88 11.53
Resistance 2 (R2) 10.88 10.46 10.98 11.44
Resistance 1 (R1) 10.51 10.19 10.70 10.69 11.34
Pivot Point 9.76 9.76 9.86 9.86 9.76
Support 1 (S1) 9.39 9.34 9.58 9.57 8.92
Support 2 (S2) 8.64 9.07 8.74 8.82
Support 3 (S3) 8.27 8.64 8.73
Support 4 (S4) 8.45